Aguzzi A, Barres BA, Bennett ML (2013). Microglia: scapegoat, saboteur, or something else? Science 339: 156–161.
Barres BA (2008). The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60: 430–440.
Beitner-Johnson D, Guitart X, Nestler EJ (1993). Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J Neurochem 61: 1766–1773.
Binns BC, Huang Y, Goettl VM, Hackshaw KV, Stephens RL Jr. (2005). Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model. Brain Res 1041: 38–47.
Borgland SL, Castanon M, Spevak W, Parkinson FE (1998). Effects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene. Can J Physiol Pharmacol 76: 1132–1138.
Bowers MS, Kalivas PW (2003). Forebrain astroglial plasticity is induced following withdrawal from repeated cocaine administration. Eur J Neurosci 17: 1273–1278.
Brown RM, Duncan JR, Stagnitti MR, Ledent C, Lawrence AJ (2012). mGlu5 and adenosine A2A receptor interactions regulate the conditioned effects of cocaine. Int J Neuropsychopharmacol 15: 995–1001.
Cata JP, Weng HR, Chen JH, Dougherty PM (2006). Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neuroscience 138: 329–338.
Cholet N, Pellerin L, Magistretti PJ, Hamel E (2002). Similar perisynaptic glial localization for the Na+,K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex. Cereb Cortex 12: 515–525.
Ciraulo DA, Sarid-Segal O, Knapp CM, Ciraulo AM, LoCastro J, Bloch DA et al (2005). Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. Addiction 100(Suppl 1): 12–22.
Cooper ZD, Jones JD, Comer SD (2012). Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opin Investig Drugs 21: 169–178.
Dzierba AL, Jelic S (2009). Chronic obstructive pulmonary disease in the elderly: an update on pharmacological management. Drugs Aging 26: 447–456.
Feltenstein MW, See RE (2008). The neurocircuitry of addiction: an overview. Br J Pharmacol 154: 261–274.
Fischer-Smith KD, Houston AC, Rebec GV (2012). Differential effects of cocaine access and withdrawal on glutamate type 1 transporter expression in rat nucleus accumbens core and shell. Neuroscience 210: 333–339.
Frampton M, Harvey RJ, Kirchner V (2003). Propentofylline for dementia. Cochrane Database Syst Rev CD002853.
Gass JT, Sinclair CM, Cleva RM, Widholm JJ, Olive MF (2011). Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol 16: 215–228.
Gipson CD, Reissner KJ, Kupchik YM, Smith AC, Staneviciute N, Hensley-Simon ME et al (2013). Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc Natl Acad Sci USA 110: 9124–9129.
Kalivas PW (2009). The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10: 561–572.
Kalivas PW, McFarland K (2003). Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168: 44–56.
Kittner B, Rossner M, Rother M (1997). Clinical trials in dementia with propentofylline. Ann N Y Acad Sci 826: 307–316.
Knackstedt LA, Melendez RI, Kalivas PW (2010). Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 67: 81–84.
Kwon OS, Chung YB, Kim MH, Hahn HG, Rhee HK, Ryu JC (1998). Pharmacokinetics of propentofylline and the quantitation of its metabolite hydroxypropentofylline in human volunteers. Arch Pharm Res 21: 698–702.
Kwon OS, Ryu JC (2000). Identification of propentofylline metabolites in rats by gas chromatography/mass spectrometry. Arch Pharm Res 23: 374–380.
LaLumiere RT, Kalivas PW (2008). Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28: 3170–3177.
Liddie S, Anderson KL, Paz A, Itzhak Y (2012). The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice. J Psychopharmacol 26: 1375–1382.
Liu W, Tang Y, Feng J (2011). Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci 89: 141–146.
Lutgen V, Kong L, Kau KS, Madayag A, Mantsch JR, Baker DA (2012). Time course of cocaine-induced behavioral and neurochemical plasticity. Addict Biol (e-pub ahead of print).
Marcusson J, Rother M, Kittner B, Rossner M, Smith RJ, Babic T et al (1997). A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. Dement Geriatr Cogn Disord 8: 320–328.
McFarland K, Lapish CC, Kalivas PW (2003). Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23: 3531–3537.
Meskini N, Nemoz G, Okyayuz-Baklouti I, Lagarde M, Prigent AF (1994). Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem Pharmacol 47: 781–788.
Mielke R, Moller HJ, Erkinjuntti T, Rosenkranz B, Rother M, Kittner B (1998). Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials. Alzheimer Dis Assoc Disord 12(Suppl 2): S29–S35.
Minelli A, Barbaresi P, Reimer RJ, Edwards RH, Conti F (2001). The glial glutamate transporter GLT-1 is localized both in the vicinity of and at distance from axon terminals in the rat cerebral cortex. Neuroscience 108: 51–59.
Moussawi K, Riegel A, Nair S, Kalivas PW (2011). Extracellular glutamate: functional compartments operate in different concentration ranges. Front Syst Neurosci 5: 1–9.
Muir RL (2009). Peripheral arterial disease: pathophysiology, risk factors, diagnosis, treatment, and prevention. J Vasc Nurs 27: 26–30.
Narita M, Miyatake M, Shibasaki M, Shindo K, Nakamura A, Kuzumaki N et al (2006). Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology 31: 2476–2488.
O'Neill CE, LeTendre ML, Bachtell RK (2012). Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats. Neuropsychopharmacology 37: 1245–1256.
Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates 5 edn. Elsevier Academic: Amsterdam.
Pekny M, Nilsson M (2005). Astrocyte activation and reactive gliosis. Glia 50: 427–434.
Reichel CM, Ramsey LA, Schwendt M, McGinty JF, See RE (2012). Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 62: 1119–1126.
Reissner KJ, Sartor GC, Vazey EM, Dunn TE, Aston-Jones G, Kalivas PW (2012). Use of vivo-morpholinos for control of protein expression in the adult rat brain. J Neurosci Methods 203: 354–360.
Reissner KJ, Uys JD, Schwacke JH, Comte-Walters S, Rutherford-Bethard JL, Dunn TE et al (2011). AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis. J Neurosci 31: 5648–5658.
Saletu B, Moller HJ, Grunberger J, Deutsch H, Rossner M (1990). Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies. Neuropsychobiology 24: 173–184.
Sari Y, Smith KD, Ali PK, Rebec GV (2009). Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J Neurosci 29: 9239–9243.
Schroeder JA, Ruta JD, Gordon JS, Rodrigues AS, Foote CC (2012). The phosphodiesterase inhibitor isobutylmethylxanthine attenuates behavioral sensitization to cocaine. Behav Pharmacol 23: 310–314.
Schwarz JM, Hutchinson MR, Bilbo SD (2011). Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. J Neurosci 31: 17835–17847.
Shigeri Y, Seal RP, Shimamoto K (2004). Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev 45: 250–265.
Sofroniew MV (2009). Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638–647.
Sondheimer I, Knackstedt LA (2011). Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking. Behav Brain Res 225: 252–258.
Soria G, Castane A, Ledent C, Parmentier M, Maldonado R, Valverde O (2006). The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine. Neuropsychopharmacology 31: 978–987.
Sung B, Lim G, Mao J (2003). Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23: 2899–2910.
Sweitzer S, De Leo J (2011). Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. Handb Exp Pharmacol 200: 235–250.
Sweitzer SM, Schubert P, DeLeo JA (2001). Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 297: 1210–1217.
Tawfik VL, Regan MR, Haenggeli C, Lacroix-Fralish ML, Nutile-McMenemy N, Perez N et al (2008). Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 152: 1086–1092.
Tilley SL (2011). Methylxanthines in asthma. Handb Exp Pharmacol 200: 439–456.
Tozzi A, de Iure A, Marsili V, Romano R, Tantucci M, Di Filippo M et al (2012). A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation. PLoS One 7: e38312.
Ward SJ, Rasmussen BA, Corley G, Henry C, Kim JK, Walker EA et al (2011). Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice. Behav Pharmacol 22: 370–373.
Watkins LR, Hutchinson MR, Rice KC, Maier SF (2009). The ‘toll’ of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 30: 581–591.
Zhong P, Wang W, Yu F, Nazari M, Liu X, Liu QS (2012). Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference. Neuropsychopharmacology 37: 2377–2387.